Steris (STE) Earnings Forecast
Analysts expect Steris (STE) to earn $11.42 a share in FY27, the average of 5 estimates as of Nov 13, 2026.
1 figure withheld by our checks. Each blank figure names its reason.
- FY27 consensus EPS
- $11.42
- 5 analysts
- FY28 consensus EPS
- $12.35
- 5 analysts · low $12.19, high $12.59
- EPS revisions, 30 days
- +1.9%
- $11.21 to $11.42
- Disagreement, FY27
- 3.6%
- high to low, $11.21 to $11.62
Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.
Analysts expect Steris to earn $13.51 a share in FY29, growing about 9% a year; 4 analysts publish an estimate for FY29.
Are estimates going up or down lately?
The FY27 EPS consensus is $11.42, up 2.4% in 91 days. Every figure compares one fiscal period at both ends.
EPS consensus, change over the last 91 days. One step per nightly change.
| EPS | 30 days | 90 daysshown above | Since Jul 2 |
|---|---|---|---|
| FY275 analysts | ▲ +1.9%$11.21 to $11.42 | ▲ +2.4%$11.15 to $11.42 | ▲ +2.3%$11.16 to $11.42 |
| FY285 analysts | ▲ +0.8%$12.25 to $12.35 | ▲ +1.7%$12.14 to $12.35 | ▲ +1.3%$12.19 to $12.35 |
| Sep '264 analysts | ◆ 0.0%$2.68 to $2.68 | ▼ −0.2%$2.69 to $2.68 | ▼ −0.5%$2.70 to $2.68 |
| Dec '264 analysts | ▼ −0.3%$2.81 to $2.80 | ▼ −0.3%$2.81 to $2.80 | ▼ −0.3%$2.81 to $2.80 |
Contributors at both ends of the window: FY27 6 and 5. A change in the average can come from a new contributor as much as from a changed mind, so both counts stay in view.
Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.
If the Street is right, what does that imply for the share price?
At 31.0 times earnings, which is what Steris trades at today, the FY28 consensus of $12.35 works out to $383 a share.
Range on the low and high estimate: $379 to $391.
Each point on the line is a multiple, and the flag is the price it implies for FY28. Past multiples are context, not a guide to future ones.
This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.
What you pay for the growth
You are paying 23.2 times the FY27 consensus for earnings the Street expects to grow about 9% a year to FY29. That is 2.6 times the growth rate.Show today's multiple against its own recordHide the multiple record
How much do analysts disagree?
For FY29, estimates run from $13.15 to $13.81 around an average of $13.51, drawn by 4 analysts.
The dashed line is FY26 filed $7.93, on the GAAP basis.
A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average.
Is next quarter a high bar or an easy one?
Analysts expect Steris to earn $2.80 a share in the December quarter, the average of 4 estimates. Results are expected by Feb 8, 2027.
low $2.78
The step from a filed quarter to a consensus crosses bases: the filed figure is the company's own GAAP number and the consensus is on the Street's basis. It is printed with both bases named, not as growth. For the March quarter, analysts expect $3.13 a share.
Does Steris usually beat or miss?
We have not been able to check a quarter yet. Our record of estimates for Steris begins on Jul 2, 2026, and a quarter can be checked only when we hold an estimate for it from before the company reported. The next report is expected by Feb 8, 2027.
We started recording estimates on Jul 2, 2026, so quarters that reported before that date cannot be checked.
Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for Steris on Jul 2, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact.
Where the growth comes from
The Street expects sales to grow 6.2% in FY28 and EPS 8.2%. Most of it is sales: the net margin moves from 17.5% to 18.1%, and the implied share count from about 97.5M to 99.0M, so these numbers assume no buyback.Show the decomposition and the margin ladderHide the decomposition
| Revenue growth | +6.2 |
|---|---|
| Net margin change | +3.6 |
| Share count change | −1.6 |
| EPS growth | +8.2 |
Coverage, and the gap to the filing
5 analysts publish an EPS estimate for FY27 and 6 publish revenue. Coverage thins with distance: 4 EPS estimates for FY29. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by year and over timeHide the coverage chart
The full consensus, year by year
Coverage thins with distance: 6 revenue estimates for FY27, 5 for FY29.
Out-year bands widen as fewer analysts publish: 5 EPS estimates for FY27, 4 for FY29.
| Fiscal year | Revenue $B | YoY | EPS $ | YoY | EBITDA $B | Net inc. $B | Shares B | Analysts rev · EPS | Fwd P/E |
|---|---|---|---|---|---|---|---|---|---|
| FY26Filed | 5.9 | — | 7.93 | — | — | — | — | as filed | 31.0× |
| FY27E | 6.46.4 to 6.4 | ▲7.4%a | 11.4211.21 to 11.62 | ▲44.0%a | 2.0 | 1.1 | 0.10 | 6 · 5 | 23.2× |
| FY28E | 6.86.7 to 6.9 | ▲6.2% | 12.3512.19 to 12.59 | ▲8.2% | 2.1 | 1.2 | 0.10 | 6 · 5 | 21.4× |
| FY29E | 7.27.1 to 7.3 | ▲6.5% | 13.5113.15 to 13.81 | ▲9.4% | 2.2 | 1.3 | 0.10 | 5 · 4 | 19.6× |
Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over the last four reported quarters, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.
Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 5 EPS estimates for FY27, 6 for revenue. Not investment advice.
Common questions
What do analysts expect Steris to earn in FY27?
Analysts expect Steris to earn $11.42 a share in FY27, the average of 5 estimates as of Nov 13, 2026.
What is Steris' earnings forecast for FY28?
The FY28 consensus for Steris is $12.35 a share from 5 analysts, with a low of $12.19 and a high of $12.59, as of Nov 13, 2026.
Have analysts raised Steris' earnings estimates?
Steris' FY27 EPS consensus rose 2.4% in 91 days, from $11.15 to $11.42, as of Nov 13, 2026.

